Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (Q29615443)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2 July 2015)

edit

Language	Label	Description	Also known as
English	Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma	scientific article (publication date: 2 July 2015)

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

title

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (English)

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

main subject

ipilimumab

0 references

author

Jean-Jacques Grob

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Piotr Rutkowski

series ordinal

10

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Pier Francesco Ferrucci

series ordinal

11

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Michele Maio

series ordinal

16

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Grant McArthur

series ordinal

18

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Georgina V. Long

series ordinal

20

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

John Wagstaff

object named as

John Wagstaff

series ordinal

13

0 references

Lars Bastholt

object named as

Lars Bastholt

series ordinal

26

0 references

Dirk Schadendorf

series ordinal

7

object named as

Dirk Schadendorf

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

Paolo Antonio Ascierto

series ordinal

19

object named as

Paolo A Ascierto

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

Mario Sznol

series ordinal

24

object named as

Mario Sznol

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

Jedd D. Wolchok

series ordinal

31

object named as

Jedd D Wolchok

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

F Stephen Hodi

series ordinal

30

object named as

F Stephen Hodi

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

James Larkin

series ordinal

1

object named as

James Larkin

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Reinhard Dummer

series ordinal

8

object named as

Reinhard Dummer

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Brigitte Dréno

series ordinal

25

object named as

Brigitte Dreno

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

author name string

Vanna Chiarion-Sileni

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Rene Gonzalez

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

C Lance Cowey

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Christopher D Lao

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Michael Smylie

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Andrew Hill

series ordinal

12

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Matteo S Carlino

series ordinal

14

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

John B Haanen

series ordinal

15

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Ivan Marquez-Rodas

series ordinal

17

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Margaret K Callahan

series ordinal

21

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Michael A Postow

series ordinal

22

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Kenneth Grossmann

series ordinal

23

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Arvin Yang

series ordinal

27

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Linda M Rollin

series ordinal

28

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Christine Horak

series ordinal

29

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

language of work or name

English

1 reference

stated in

PubMed

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=26027431

retrieved

30 April 2017

publication date

31 May 2015

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

published in

The New England Journal of Medicine

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

volume

373

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

issue

1

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

page(s)

23-34

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

cites work

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Nivolumab in previously untreated melanoma without BRAF mutation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Improved overall survival in melanoma with combined dabrafenib and trametinib

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Pathways and therapeutic targets in melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Nivolumab plus ipilimumab in advanced melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

3 June 2018

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698905

retrieved

26 November 2018

Identifiers

DOI

10.1056/NEJMOA1504030

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

Fatcat ID

release_ytkpsvr3grb4lmomgg4l55fpgu

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/ytkpsvr3grb4lmomgg4l55fpgu

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

42171

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

42171

PMCID

5698905

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

PubMed ID

26027431

1 reference

stated in

Europe PubMed Central

PMCID

5698905

retrieved

8 January 2018

reference URL

http://europepmc.org/abstract/PMC/5698905

ResearchGate publication ID

277560158

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29615443&oldid=2137716765"